Doctor profile · Federal record
Dr. Kelly Wilber, APRN
Nurse Practitioner · Adult Health Nurse Practitioner · Waterbury, CT
- NPI 1255520219
- Accepts Medicare
- MIPS 83.5 / 100 · 2023
- 19 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
500 Chase Pkwy
Waterbury, CT 067083346
(203) 755-6677
Credentials & registration
- NPI registered
- October 2007 — 19 yrs on file
- Profile last updated
- May 23, 2025
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Connecticut #003628
- Medicaid
- CT #1255520219
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1255520219. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,741
Distinct HCPCS
4
Medicare allowed
$191,965
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,100 | 189 | $114 | |
80307 |
Testing for presence of drug, by chemistry analyzers | 282 | 130 | $60 | |
G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 281 | 128 | $152 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 78 | 38 | $81 |
In context: peer comparison
Among 4 peers in Waterbury Nurse Practitioner, average services per provider: 246. This provider delivers 7.1× the peer median.Open Payments
Industry payments received
All-time total
$4,522
Transactions
131
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 12 | $2,608.21 | |
| Collegium Pharmaceutical, INC. | 44 | $561.41 | |
| Scilex Pharmaceuticals INC. | 13 | $317.54 | |
| Abbvie INC. | 12 | $252.50 | |
| Averitas Pharma INC. | 8 | $250.92 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 25 | $185.99 | |
| Azurity Pharmaceuticals, INC. | 5 | $90.11 | |
| TerSera Therapeutics LLC | 4 | $72.60 | |
| Medtronic, INC. | 2 | $48.04 | |
| Lundbeck LLC | 1 | $34.25 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $25.76 | |
| Pfizer INC. | 1 | $22.32 | |
| Nalu Medical, INC. | 1 | $19.53 | |
| Bioventus LLC | 1 | $18.64 | |
| Fidia Pharma USA INC. | 1 | $14.53 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
6,182
Patients
1,256
Total drug cost
$763,103
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 1,329 | 200 | $34,381 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 975 | 187 | $29,704 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 515 | 93 | $19,621 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 440 | 77 | $10,694 |
| Gabapentin | Generic | 415 | 91 | $9,894 |
| Hydromorphone Hcl | Generic | 402 | 94 | $6,006 |
| Belbuca (Buprenorphine Hcl) | Brand | 321 | 49 | $304,340 |
| Tizanidine Hcl | Generic | 317 | 93 | $5,209 |
| Buprenorphine | Generic | 289 | 75 | $104,720 |
| Tramadol Hcl | Generic | 281 | 69 | $3,942 |
Frequently asked questions
What is Dr. Kelly Wilber's medical specialty?
Dr. Kelly Wilber practices Nurse Practitioner in Waterbury, CT.
Where does Dr. Kelly Wilber practice?
Dr. Kelly Wilber practices at 500 Chase Pkwy, Waterbury, CT 067083346. Office phone: 2037556677.
What is Dr. Kelly Wilber's NPI?
Dr. Kelly Wilber's National Provider Identifier (NPI) is 1255520219, issued by NPPES.
Does Dr. Kelly Wilber accept Medicare assignment?
Yes. Dr. Kelly Wilber accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kelly Wilber commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS G0481). Source: CMS Medicare Physician & Other Practitioners file.